🇰🇷 South Korea Country × Condition
ulcerative colitis Clinical Trials in South Korea
Active clinical trials for ulcerative colitis with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT05428345
Recruiting
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Enrollment
600 pts
Country
🇰🇷 South Korea
Takeda
View Trial → NCT06073873
Recruiting
A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea
Enrollment
3,000 pts
Country
🇰🇷 South Korea
Bristol-Myers Squibb
View Trial → Frequently Asked Questions
How many ulcerative colitis clinical trials are active in South Korea?
There are currently 2 active clinical trials for ulcerative colitis with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a ulcerative colitis clinical trial in South Korea?
To join a ulcerative colitis clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ulcerative colitis trials in South Korea?
Active ulcerative colitis trials in South Korea span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology